These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 20651055)

  • 1. Upregulation of SOX9 in lung adenocarcinoma and its involvement in the regulation of cell growth and tumorigenicity.
    Jiang SS; Fang WT; Hou YH; Huang SF; Yen BL; Chang JL; Li SM; Liu HP; Liu YL; Huang CT; Li YW; Jang TH; Chan SH; Yang SJ; Hsiung CA; Wu CW; Wang LH; Chang IS
    Clin Cancer Res; 2010 Sep; 16(17):4363-73. PubMed ID: 20651055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stomatin-like protein 2 is overexpressed in cancer and involved in regulating cell growth and cell adhesion in human esophageal squamous cell carcinoma.
    Zhang L; Ding F; Cao W; Liu Z; Liu W; Yu Z; Wu Y; Li W; Li Y; Liu Z
    Clin Cancer Res; 2006 Mar; 12(5):1639-46. PubMed ID: 16533792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenylate kinase-4 is a marker of poor clinical outcomes that promotes metastasis of lung cancer by downregulating the transcription factor ATF3.
    Jan YH; Tsai HY; Yang CJ; Huang MS; Yang YF; Lai TC; Lee CH; Jeng YM; Huang CY; Su JL; Chuang YJ; Hsiao M
    Cancer Res; 2012 Oct; 72(19):5119-29. PubMed ID: 23002211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of cell-type specific profiles in tissues and isolated cells from squamous cell carcinomas of the lung.
    Hawthorn L; Stein L; Panzarella J; Loewen GM; Baumann H
    Lung Cancer; 2006 Aug; 53(2):129-42. PubMed ID: 16757060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotensin receptor 1 determines the outcome of non-small cell lung cancer.
    Alifano M; Souazé F; Dupouy S; Camilleri-Broët S; Younes M; Ahmed-Zaïd SM; Takahashi T; Cancellieri A; Damiani S; Boaron M; Broët P; Miller LD; Gespach C; Regnard JF; Forgez P
    Clin Cancer Res; 2010 Sep; 16(17):4401-10. PubMed ID: 20810387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma.
    Tsai MF; Wang CC; Chang GC; Chen CY; Chen HY; Cheng CL; Yang YP; Wu CY; Shih FY; Liu CC; Lin HP; Jou YS; Lin SC; Lin CW; Chen WJ; Chan WK; Chen JJ; Yang PC
    J Natl Cancer Inst; 2006 Jun; 98(12):825-38. PubMed ID: 16788156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetic characterization and gene expression profiling in the rat reflux-induced esophageal tumor model.
    Bonde P; Sui G; Dhara S; Wang J; Broor A; Kim IF; Wiley JE; Marti G; Duncan M; Jaffee E; Montgomery E; Maitra A; Harmon JW
    J Thorac Cardiovasc Surg; 2007 Mar; 133(3):763-9. PubMed ID: 17320581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of matrilin-3 not only in osteoarthritic articular cartilage but also in cartilage-forming tumors, and down-regulation of SOX9 via epidermal growth factor domain 1-dependent signaling.
    Vincourt JB; Vignaud JM; Lionneton F; Sirveaux F; Kawaki H; Marchal S; Lomazzi S; Plénat F; Guillemin F; Netter P; Takigawa M; Mainard D; Magdalou J
    Arthritis Rheum; 2008 Sep; 58(9):2798-808. PubMed ID: 18759284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNA-145 suppresses lung adenocarcinoma-initiating cell proliferation by targeting OCT4.
    Yin R; Zhang S; Wu Y; Fan X; Jiang F; Zhang Z; Feng D; Guo X; Xu L
    Oncol Rep; 2011 Jun; 25(6):1747-54. PubMed ID: 21479367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of the LGALS3 (galectin 3) gene in human non-small-cell lung cancer.
    Yoshimura A; Gemma A; Hosoya Y; Komaki E; Hosomi Y; Okano T; Takenaka K; Matuda K; Seike M; Uematsu K; Hibino S; Shibuya M; Yamada T; Hirohashi S; Kudoh S
    Genes Chromosomes Cancer; 2003 Jun; 37(2):159-64. PubMed ID: 12696064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paracrine and autocrine signals promoting full chondrogenic differentiation of a mesoblastic cell line.
    Locker M; Kellermann O; Boucquey M; Khun H; Huerre M; Poliard A
    J Bone Miner Res; 2004 Jan; 19(1):100-10. PubMed ID: 14753742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrin alpha 11 regulates IGF2 expression in fibroblasts to enhance tumorigenicity of human non-small-cell lung cancer cells.
    Zhu CQ; Popova SN; Brown ER; Barsyte-Lovejoy D; Navab R; Shih W; Li M; Lu M; Jurisica I; Penn LZ; Gullberg D; Tsao MS
    Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11754-9. PubMed ID: 17600088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation and growth inhibitory role of C/EBPalpha in breast cancer.
    Gery S; Tanosaki S; Bose S; Bose N; Vadgama J; Koeffler HP
    Clin Cancer Res; 2005 May; 11(9):3184-90. PubMed ID: 15867211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of dalteparin, a kind of low molecular weight heparin, on lung adenocarcinoma A549 cell line in vitro.
    Chen X; Xiao W; Qu X; Zhou S
    Cancer Invest; 2008 Aug; 26(7):718-24. PubMed ID: 18608211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined functional genome survey of therapeutic targets for hepatocellular carcinoma.
    Satow R; Shitashige M; Kanai Y; Takeshita F; Ojima H; Jigami T; Honda K; Kosuge T; Ochiya T; Hirohashi S; Yamada T
    Clin Cancer Res; 2010 May; 16(9):2518-28. PubMed ID: 20388846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts.
    Zhang W; Chen Y; Wei H; Zheng C; Sun R; Zhang J; Tian Z
    Clin Cancer Res; 2008 Oct; 14(20):6432-9. PubMed ID: 18927282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of inhabitation of VEGF expression with RNA interference on lung cancer therapy].
    Zhang Y; Gu ZP; Zhou YA; Wang YJ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Apr; 25(4):341-3, 347. PubMed ID: 19351507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiniSOX9, a dominant-negative variant in colon cancer cells.
    Abdel-Samad R; Zalzali H; Rammah C; Giraud J; Naudin C; Dupasquier S; Poulat F; Boizet-Bonhoure B; Lumbroso S; Mouzat K; Bonnans C; Pignodel C; Raynaud P; Fort P; Quittau-Prévostel C; Blache P
    Oncogene; 2011 Jun; 30(22):2493-503. PubMed ID: 21297661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methyl CpG-binding domain protein 3 mediates cancer-selective cytotoxicity by histone deacetylase inhibitors via differential transcriptional reprogramming in lung cancer cells.
    Noh EJ; Jang ER; Jeong G; Lee YM; Min CK; Lee JS
    Cancer Res; 2005 Dec; 65(24):11400-10. PubMed ID: 16357148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research on expression and control of p16 and p21 by wild-type p53 gene in two lung adenocarcinoma cell lines].
    Jin Y; Yan CH; Wu Y; Liu Y; Zhang GY; Li P; Fu SB
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Oct; 20(5):409-12. PubMed ID: 14556194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.